false
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Catalog
SCAI Bifurcation Club - A Case-Based Discussion
DCB in Bifurcation PCI, Dr. Goran Stankovic
DCB in Bifurcation PCI, Dr. Goran Stankovic
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The discussion centered on the use of Drug-Coated Balloons (DCB) in treating coronary bifurcations, highlighting its advantages over stents. DCBs ensure the original anatomy of bifurcations is maintained and deliver drugs directly to vessel walls, avoiding issues related to stents, such as malapposition and complicated procedural steps. Initial studies, like PEPCAT 5 and the Belgian study, showed limited success in using DCBs with bare metal stents. A meta-analysis indicated reduced late lumen loss with DCB for side branches, yet without significant clinical outcome improvements. Current strategies explore combining DCB with drug-eluting stent (DES) in main branches, which shows promise in maintaining side branch patency. Ongoing research seeks optimal DCB strategies, like applying it sequentially in both branches, which has shown encouraging results. However, more data is needed to refine these approaches and establish effective protocols, particularly concerning potential suboptimal initial lumen appearance that might improve over time.
Keywords
Drug-Coated Balloons
coronary bifurcations
stents
meta-analysis
clinical outcomes
×